Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 29, 2016
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
Geoff Meacham Downgraded (VRTX) to Hold on, Nov 29th, 2016
Geoff Meacham of Barclays, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold on, Nov 29th, 2016.
Geoff has made no other calls on VRTX in the last 4 months.
There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 3 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Hold and Held Target at $98 on, Friday, November 18th, 2016
- Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
- Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016
This is the rating of the analyst that currently disagrees with Geoff
- Biren Amin of "Jefferies" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, October 5th, 2016
